SEARCH

Current Edition

COVID-19

Merck agrees to license COVID-19 pill widely through pact with patent group

Merck’s pill has the potential to alter the course of the pandemic. Earlier this month, the company and partner Ridgeback Biotherapeutics released data showing molnupiravir …

Continue Reading →